Chemoinformaics analysis of 1,2-Dehydrosesquicineole
| Molecular Weight | 220.356 | nRot | 3 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 22 |
| Exact Molecular Weight | 220.183 | nRing | 3 |
| Solubility: LogS | -4.218 | nHRing | 2 |
| Solubility: LogP | 1.941 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 41.855 |
| nHD | 0 | BPOL | 25.813 |
| QED | 0.748 |
| Synth | 4.191 |
| Natural Product Likeliness | 2.816 |
| NR-PPAR-gamma | 0.016 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.729 |
| Pgp-sub | 0.004 |
| HIA | 0.043 |
| CACO-2 | -4.813 |
| MDCK | 0.0000257 |
| BBB | 0.966 |
| PPB | 0.915045 |
| VDSS | 1.194 |
| FU | 0.0525431 |
| CYP1A2-inh | 0.025 |
| CYP1A2-sub | 0.747 |
| CYP2c19-inh | 0.101 |
| CYP2c19-sub | 0.841 |
| CYP2c9-inh | 0.088 |
| CYP2c9-sub | 0.556 |
| CYP2d6-inh | 0.155 |
| CYP2d6-sub | 0.091 |
| CYP3a4-inh | 0.605 |
| CYP3a4-sub | 0.856 |
| CL | 15.153 |
| T12 | 0.852 |
| hERG | 0.019 |
| Ames | 0.011 |
| ROA | 0.168 |
| SkinSen | 0.027 |
| Carcinogencity | 0.91 |
| EI | 0.012 |
| Respiratory | 0.918 |
| NR-Aromatase | 0.231 |
| Antiviral | Yes |
| Prediction | 0.887209 |